Treatment with CCC decreased the adipose tissue of the HFD-induced obese rats. by Hyoung Joon Park (437458)

“…The means sharing a common letter do not significantly differ. …”

BSO treatment decreases E2F target gene expression. by Hannes M. Findeisen (353287)

Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells. by Xianzhou Song (803006)

“…<p>(A) Western blot shows that bufalin (100 nM) downregulates SRC–3 protein levels in TNBC cells. …”

Pan-neuronal <i>Nmdar1</i> knockdown decreases sleep. by Jun Tomita (185170)

FX06 decreased capillary leak following LPS injection in rats. by Marion Gröger (264663)

The PKA pathway compensates for decreased RAM pathway activity during morphogenesis. by Nike Bharucha (222826)

Incubation with normal human serum decreases neutrophil anti-gonococcal activity. by Lacie M. Werner (14710419)

Pregnancy is associated with decreased polyubiquitinated protein levels, but not de-ubiqutination levels. by Andrea Iorga (298552)

BMMC therapy decreases the presence of macrophages and cells reactive for iNOS. by Miquéias Lopes-Pacheco (641924)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Scale bars represent 100 μm. Migration was reported as mean percent area positive ± SEM and invasion reported as mean number of cells ± SEM. …”

Reduction of Tks5 expression in tumor cells is associated with decreased angiogenesis. by Barbara Blouw (715467)

Chronic RAS blockade decreases AT₁R expression. by Lai Ming Yung (353970)

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

IFNγ activates STAT signaling and decreases cell viability of NPCs. by Johanna Mäkelä (223358)

TIPE2 deficiency increases NO production but decreases urea production in macropahges. by Yunwei Lou (560831)

IFNγ decreases cell proliferation of NPCs via p21. by Johanna Mäkelä (223358)

“…(<b>E</b>) NPCs were treated with siRNA against p21 for 2 days followed by IFNγ for 24 h Upper panel, Immunoblots showing p-vimentin as a measure of cell proliferation. IFNγ decreased p-vimentin in control but not in p21-siRNA treated cells. …”

An androgen antagonist decreases the levels of Rubicon and GATA4 in Sertoli cells. by Tadashi Yamamuro (6955694)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Thick Matrigel leads to decreased F-actin cell spread areas. by Michael K. Wong (646399)